Enterprise to Participate in Investor Conferences
Get Alerts EPD Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
Revenue Growth %: +19.5%
Join SI Premium – FREE
HOUSTON--(BUSINESS WIRE)-- Enterprise Products Partners L.P. (NYSE: EPD) announced today that it will participate in meetings with investors at the following conferences in New York City:
- Mizuho Power, Energy & Infrastructure Conference, December 9, 2024; and
- Wells Fargo 23rd Annual Midstream, Energy & Utilities Symposium, December 10-11, 2024.
The latest investor deck that may be used to facilitate the investor meetings can be accessed under the Investors tab on the Enterprise website.
Enterprise Products Partners L.P. is one of the largest publicly traded partnerships and a leading North American provider of midstream energy services to producers and consumers of natural gas, NGLs, crude oil, refined products and petrochemicals. Services include: natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage and marine terminals; crude oil gathering, transportation, storage and marine terminals; petrochemical and refined products transportation, storage and marine terminals; and a marine transportation business that operates on key U.S. inland and intracoastal waterway systems. The partnership’s assets currently include more than 50,000 miles of pipelines; over 300 million barrels of storage capacity for NGLs, crude oil, petrochemicals and refined products; and 14 billion cubic feet of natural gas storage capacity. Please visit www.enterpriseproducts.com for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241206891687/en/
Libby Strait, Investor Relations, (713) 381-4754, [email protected]
Rick Rainey, Media Relations, (713) 381-3635, [email protected]
Source: Enterprise Products Partners L.P.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pursuit Announces Date for Second Quarter 2026 Earnings Release and Conference Call
- Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
- Ceravindo Introduces AI-Driven Trading Platform to Support Australian Investors with Smarter Market Insights
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Crude Oil, Wells Fargo, MizuhoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share